Rare diseases
Investigational molecules
Locations
Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
SpainStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
SpainStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
SpainStudy on Venetoclax, Azacitidine, and Cusatuzumab for Newly Diagnosed Acute Myeloid Leukemia Patients Not Suitable for Intensive Therapy
SpainStudy Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma
SpainStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
SpainStudy of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers
SpainStudy on Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to Current Treatment
SpainStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
SpainStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
SpainStudy of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
